Efrat Dotan, MD

GI Oncology Now

<p>At the 2025 American Society of Clinical Oncology Gastrointestinal Cancers Symposium, Efrat Dotan, MD, of Ann B Barshinger Cancer Institute at Lancaster General Health, shared the effects of baseline geriatric and quality of life assessments on treatment outcomes for older patients with metastatic pancreatic cancer.</p>


Lauren Dembeck, PhD

Disitamab Vedotin Regimens Effective in HER2+ Gastric Cancer

Esophageal Cancer

Jeanne Tie, MD, MBChB

DYNAMIC-III's ctDNA-Positive Cohort: Utilizing ctDNA to Guide Adjuvant Chemotherapy Escalation in Patients With Stage III Colon Cancer

ASCO 2025

Zev Wainberg, MD, MSc

MATTERHORN: Practice-Changing Treatment Paradigm for Resectable G/GEJ Cancers

Gastric Cancer

Latest News

Effect of Baseline Geriatric, QOL Assessments on Treatment Outcomes in the GIANT Study

Pancreatic Cancer

Dr. Dotan shared the effects of baseline geriatric and QOL assessments on outcomes for older patients with pancreatic cancer.

Baseline Geriatric, QOL Assessments and Treatment Outcomes in GIANT

About Us

Editorial Policy

Advertising

eNewsletters

Contribute

GU Oncology Now

Lung Cancers Today

Cancer Nursing Today

DocWire News

MashupMD

Bile Duct

Colorectal

Esophageal

Gastric

GEP-NETs

GIST

Liver

Pancreatic

Conference Coverage

Video Insights

Roundtable